Trust Board Meeting: Wednesday 13 May 2015 TB2015.56 Title Proposal for the Relocation of Respiratory Inpatient and Cystic Fibrosis Services to the John Radcliffe Site Status For decision History Considered by the Trust Management Executive at its meeting on 23 April 2015, and supported for submission to the Trust Board Board Lead(s) Mr Paul Brennan, Director of Clinical Services Key purpose Strategy TB2015.56 Proposal for Respiratory Relocation Assurance Policy Performance Page 1 of 18 Oxford University Hospitals TB2015.56 Executive Summary 1. This business case is to outline the proposed reconfiguration of respiratory services to move inpatient services to the John Radcliffe site in line with the Trust agreed strategy for the configuration of its services. 2. A plan has been developed to move the Respiratory in-patients from Geoffrey Harris Ward at the Churchill to a 21-bedded respiratory ward on Level 7 at the JR as a result of the vacation of the Community Hospital ward and 6 dedicated Cystic Fibrosis beds on 5C/D. The relocation plan also includes the move of the Cystic Fibrosis and Bronchiectasis outpatient and treatment unit which currently operates out of the Respiratory Day Case Unit which was condemned in December 2011. This service will relocate to a dedicated area within Blue outpatients with access to gym facilities on Level 2. The location of the Respiratory inpatient ward on the John Radcliffe Hospital site will improve the pathway for acute respiratory inpatient admissions and support the implementation of the Acute General Medicine Review from 2012. The services will also join the Respiratory interventional unit (bronchoscopy and thoracoscopy) and overnight sleep studies services which moved to the JR during 2014. 3. The capital investment required for the reconfiguration of the ward on Level 7 is estimated as £1,958k which includes extensive refurbishment, installation of medical gases, removal of asbestos and installation of ducting to allow future installation of mechanical ventilation. Derogation in place for a period of 2 years following which a further assessment will need to be made re the installation of the mechanical ventilation. It also includes the purchase of equipment for the move including replacement monitoring for the service’s high care beds; bedside EPR computers and the location of a lung function testing room within blue outpatients to support comprehensive lung function studies on respiratory patients but also other patients such as cardiothoracic who require these tests prior to surgery. Provision has been made for this proposal in the Trust capital programme. 4. In addition, there is a requirement for £330k revenue investment as this move will result in a number of staff and teams needing to work on a split-site basis. It will also require investment in consultant time to maintain outpatient clinics and junior doctors to enable the provision of robust out-of-hours rotas for respiratory medical cover. The Division is committed to reducing the additional costs over time as other efficiencies are realised as a result of the new configuration and closer working between Respiratory and Acute General Medicine 5. Following this move, the configuration of Respiratory Medicine will be as follows: The Churchill site will maintain most general and sub-specialist outpatients; Sleep and Ventilation set-ups; lung function tests; Radiology exams including overnight admission for respiratory radiology procedures. Some pleural procedures will also continue at the Churchill site in Radiology. The John Radcliffe site will host general and Cystic Fibrosis Respiratory inpatients; Cystic Fibrosis outpatients and day case treatments; Interventional procedures including bronchoscopy and pleural procedures; inpatient sleep studies. In addition, the Horton hospital also provides respiratory outpatients, bronchoscopy procedures and lung function tests. TB2015.56 Proposal for Respiratory Relocation Page 2 of 18 Oxford University Hospitals TB2015.56 6. To approve this business case and the capital and revenue investment required to support the delivery of the relocation of Respiratory inpatient services and adult cystic fibrosis services to the John Radcliffe site. 7. To support the continued work of the MRC division to realise efficiencies associated with improvements to patient flow as a result of the new location of services. 8. Recommendation The Trust Board is asked to: To approve this business case and the capital and revenue investment required to support the delivery of the relocation of Respiratory inpatient services and adult cystic fibrosis services to the John Radcliffe site. To support the continued work of the MRC division to realise efficiencies associated with improvements to patient flow as a result of the new location of services. TB2015.56 Proposal for Respiratory Relocation Page 3 of 18 Oxford University Hospitals TB2015.56 Proposal for the Relocation of Respiratory Inpatient and Cystic Fibrosis Services to the John Radcliffe Site Trust Management Executive Reference TME2015.107 Appendices Appendix A – Financial Pro Forma Appendix B – Ward Refurbishment Works costing assessment Appendix C – Risk and Action log for the Relocation Plan Appendix D – Equality Impact Assessment TBC Background papers (if any) Action/decision required from SPC To approve the plans for relocation of respiratory services to the John Radcliffe Site To approve the additional resources required to facilitate this move which are: Capital:£1,958k Revenue:£330k p.a. To acknowledge the risk associated with the remaining respiratory services remaining in their current location at the Churchill site and to support finding a solution for these issues To acknowledge the risks associated with relocation and to support the organisation in managing these risks Strategic Objective(s) that the case will SO1 To be a patient-centred help deliver organisation, providing high quality and compassionate care, with integrity and respect for patients and staff – “delivering compassionate excellence” SO4 To provide high quality general acute healthcare services to the population of Oxfordshire, including more joined-up care across local health and social care services – “delivering integrated healthcare” SO5 To develop extended clinical networks that benefit our partners and the people they serve. This will support the delivery of safe and sustainable services throughout the network of care TB2015.56 Proposal for Respiratory Relocation Page 4 of 18 Oxford University Hospitals TB2015.56 that we are part of and our provision of high quality specialist care for the people of Oxfordshire and beyond – “excellent secondary and specialist care through sustainable clinical networks.” Proposed date that revenue spend will October 2015 begin: Proposed date that capital spend will May 2015 begin: Conclusion of Equality Analysis The relocation of Respiratory inpatient services will increase the availability of respiratory expertise in the management of acute hospital medical admissions and improve the overall delivery of care for these patients The relocation doesn’t address the accommodation needs for respiratory outpatients and solutions will need to be found to address this. Review Date April 2016 Acronyms and abbreviations used BTS – British Thoracic Society OCDEM – Oxford Centre for Diabetes, Endocrine and Metabolism NIV – Non-invasive Ventilation CPAP – Pressure Author (s) Continuous Mrs Kathryn Manager Positive Airway Hall, Operational Service Dr Maxine Hardinge, Clinical Lead for Respiratory Services Lead Finance Manager TB2015.56 Proposal for Respiratory Relocation Mr Andrew Hall, Interim Senior Business Partner, MRC Division Page 5 of 18 Oxford University Hospitals TB2015.56 Proposal for the Relocation of Respiratory Inpatient and Cystic Fibrosis Services to the John Radcliffe Site 1. Strategic Context and Case for Change 1.1. The Trust’s Two Year Business Plan 2014/15-15/16 (TB2014.58) as part of the delivery of its clinical strategy stated the requirement to “Optimise the configuration of services across the Trust’s four sites”. This would be delivered through a number of actions including “Support the strengthening of acute services by the transfer of medical sub-specialities to the JR site to provide enhanced and more responsive support”. For respiratory services and Infectious Diseases, this would be achieved through: Agreement of strategy and location Completion and approval of business case Completion of necessary works Relocation of services. 1.2. The Respiratory Service produced a Strategy document which was approved by TME in the autumn of 2014. This strategy outlined the long term goal for the location and development of all Respiratory services. This business case is a step in the delivery of that strategy. 2. Current Service Configuration 2.1. The Oxford Centre for Respiratory Medicine is currently located on the old Churchill Hospital site. The service comprises of the following departments: 2.1.1. A 24-bedded ward located in the OCDEM (Oxford Centre for Diabetes, Endocrine and Metabolism) building which is shared with Diabetes and Endocrine patients. The ward is nominally split with 18 beds for Respiratory and 6 beds for Endocrine/Diabetes but the bed usage is flexible according to the demand. Respiratory patients frequently exceed 18 beds and will also outlie on John Warin ward (Infectious Diseases), and the Renal ward. There is an average of 4 outliers per day on the Churchill site and there is also an average of 5 patients per day awaiting transfer /admission from the John Radcliffe site for Respiratory management. 2.1.2. A 10-bedded day case unit which is located on the east side of the hospital site down the corridor from the old east entrance. The day case unit is used by a number of services including: A rapid access service which is designed for patients who are known to the respiratory service and may be deteriorating. GPs are able to access this service for urgent intervention to avoid admission (NB this service has not been operating during 2014/15 due to the inability to recruit to the nursing posts required to support the unit). Cystic Fibrosis day case assessment and treatment for patients who require support and intervention, e.g. IV infusions. Day case set-up of Non-Invasive Ventilation (NIV) or Continuous Positive Airways Pressure (CPAP) for sleep and ventilation patients who are going home to continue their treatment. This is an alternative to hospital admission which is standard care in many TB2015.56 Proposal for Respiratory Relocation Page 6 of 18 Oxford University Hospitals TB2015.56 other large sleep centres. There is also space for a group education session for patients and their carers to provide them with advice and guidance for their on-going treatment. A base for the collection and deposit of equipment for home-based sleep studies for the sleep and ventilation service. Day case IV infusion treatments with Omalizumab (severe asthma patients) and Infliximab (Dermatology patients with complex psoriasis) which have to be administered under medical supervision. (NB this service relocated to a side-room on the Respiratory ward due to a lack of nursing staff as a result of recruitment and retention problems in 2014). Respiratory physiotherapy out-patients including a gym and exercise area for general Respiratory patients and Cystic Fibrosis patients. A long-term oxygen therapy and ambulatory oxygen therapy assessment service provided by the Home Oxygen Service, part of the Oxford Health Respiratory nursing team OUH provide Consultant supervision for this service and facilities (arterial blood gas machine) which are not available in the community. A two-bedded research area for patients currently undergoing clinical trials through research projects with the University and the BRC. 2.1.3. A Lung Function Laboratory which is the only OUH diagnostic lung function facility. Lung function tests support the diagnosis and monitoring of respiratory patients but also forms part of the range of assessments needed for patients who are having surgery or chemotherapy and radiotherapy treatment for Cancer. This service is almost in continuous use and sees approximately 130 patients per week. 2.1.4. An Outpatient department with 9 clinic rooms and a reception area. This provides out-patient facilities for approximately 20,000 patients per annum. 2.1.5. An office area for the following staff: 2.1.6. 12 consultants in shared offices 1 unit manager 4 SPRs 14 A&C staff 3 Lung Cancer Specialist Nurses, MDT Co-ordinator and Tracker 4 Oxford Health Community TB nurses 4 Oxford Health Community Respiratory Nurses Notes Storage. The offices are mostly shared except those which are too small to accommodate any more than 1 person. There is a staff coffee room and seminar room for medical/nursing education which is used by many other services on site. The Oxford Clinical Trials Department which coordinates regional and national respiratory trials is located in the old Occupational Health suite at the bottom of the corridor on the East side. TB2015.56 Proposal for Respiratory Relocation Page 7 of 18 Oxford University Hospitals TB2015.56 2.2. During 2014, two services within Respiratory Medicine successfully relocated to the John Radcliffe site. In February 2014, the inpatient sleep study service moved to the Geratology Day Unit (Lionel Coisins) and uses the outpatient and treatment rooms overnight. In July 2014, the Interventional service which supports the provision of bronchoscopy, thoracoscopy and pleural procedures, moved to JR Theatres. This followed a previous move to Churchill Radiology after the procedure room within the old Respiratory Day Unit was condemned for interventional use in 2013 due to problems with oxygen and suction. The move to the JR has greatly improved the available capacity for procedures and has supported a reduction in the diagnostic part of the lung cancer pathway as the original relocation to Churchill Radiology was very limited due to limited access to recovery space. 3. Estate Issues for the Existing Accommodation 3.1. There are significant problems with the existing accommodation for Respiratory Medicine at the Churchill: 3.1.1. The ward (Geoffrey Harris ward) is located in newer accommodation in the OCDEM building which was opened circa 2004 but this ward is not without problems. The fabric of the building means that it can be very hot in the summer and very cold in the winter. There have been regular problems with leaks in the roof during heavy rain. In addition, the ward fails to comply with appropriate standards for evacuation in the event of a fire. One end of the ward is accessible for escape but the other will not support the evacuation of bed-bound patients. Patients are also not able to evacuate vertically due to the lack of back-up power supply for the lifts in the building and the ward is located on the first floor. During a power failure in 2014, there was a significant delay to the transfer of a patient to Critical Care due to the inability to move the patient down a flight of stairs. 3.1.2. With the exception of the ward, all Respiratory services are supported by power cables which date back to the Second World War and are of a particularly specialist nature (wrapped in oiled paper) and there are a very limited number of people who are able to work with such cables. The last power failure was in March 2012 and Estates have advised that the service can expect another power failure at any time. The March 2012 power failure lasted 4 days and was significantly disruptive to the service resulting in patients being cancelled where they could not be safely relocated. The power failure effected all departments and there is only one back-up power supply plug in the entire area. 3.1.3. The existing accommodation does not comply with current infection control standards for cleaning: The day case area has poor building fabric particularly around the windows, edges of the side-rooms, the sluice room and kitchen area. There are large areas of wood which cannot be cleaned to the recommended standard. In the autumn of 2011, following an executive walk-round, it was recommended that the department should close by Christmas 2011 as it was considered unsafe for patients. To date, it has not been possible to achieve this closure due to the significant disruption to existing patient services and the TB2015.56 Proposal for Respiratory Relocation Page 8 of 18 Oxford University Hospitals 4. TB2015.56 difficulty in finding alternative clinical space. The department is regularly audited for cleaning standards and monitored for any incidents associated with hygiene or the environment to ensure that patients remain safe. To date, there have been no incidents in respect of this matter. The outpatient accommodation has similar building fabric problems with windows that cannot be opened and closed appropriately and does not comply with current infection control standards for cleaning. Demand for outpatient clinics has increased in the last few years and on busy clinic days there is insufficient space for patients to wait comfortably for their appointment. The outpatient department is located on the old side of the hospital whereas the Radiology department is located in the new Cancer Centre. This distance is very difficult for patients who are suffering with breathing problems and there is consistent patient feedback from Outpatient Surveys regarding this. There is no space to provide a plain film x-ray facility for Chest x-rays within the respiratory outpatient department. None of the departments have been redecorated for several years and this contributes to the shabby appearance of the area and also adds to the difficulties in presenting an environment that is clinically clean. The main corridor and the lung function corridor are similarly shabby with inappropriate fabric for a clinic area and more recently several species of pests have been spotted in the main corridor area which again contributes to a poor environmental appearance for the services as well as concerns for cleanliness and infection control standards. Impact and Risk of the Split between Respiratory and Acute General Medicine 4.1. The site split between Acute General Medicine based at the John Radcliffe Hospital site and Respiratory at the Churchill site causes significant problems with the patient pathway. 4.1.1. Emergency admissions present at the John Radcliffe hospital site. A significant percentage of these admissions will have a respiratory problem as part of their primary diagnosis. There are insufficient specialist respiratory beds to transfer all these patients across to the Churchill and often the patients require input from a number of specialists many of whom are located at the JR. 4.1.2. The separate site configuration and the fact that the Respiratory service has an extensive outpatient population and a commitment to the Respiratory ward and immediate outliers on the Churchill site means that within current staffing levels, it is difficult to provide a timely response for Respiratory patients at the John Radcliffe site. 4.1.3. The split-site configuration means that it is not easy to ‘exchange’ patients – in effect, to take the more acutely unwell respiratory patients onto the respiratory ward and move a more able respiratory patient to another ward prior to discharge. TB2015.56 Proposal for Respiratory Relocation Page 9 of 18 Oxford University Hospitals 5. TB2015.56 4.1.4. Respiratory medicine is consistently busy but also suffers seasonal spikes in demand, particularly during winter. 4.1.5. The split site configuration also has a potential impact on the length of stay for patients with respiratory conditions and ‘frequent flyers’ are not always able to receive immediate intervention that could send them home without the need for admission. 4.1.6. The split-site configuration does not ably support the new model for Medicine with the timely intervention of a specialist opinion to facilitate effective and efficient patient management for patients admitted via Acute General Medicine. Case for Change – Relocation of Respiratory Services 5.1. There is an opportunity to relocate the Respiratory ward to the John Radcliffe site through the vacation of Ward 7E following the departure of the City Community Ward. This would create a 21-bedded ward which would include 2 High care beds for patients who are on basic or advanced Respiratory support. This ward alone would not accommodate all of the Respiratory patients including its outliers but there is also the opportunity to accommodate the Cystic Fibrosis patients on Ward 5C/D and to do so within that ward’s existing establishment. Ward 5C/D used to be the Private Patient ward and each bed is in a single room with an en-suite and this would be ideal for the Cystic Fibrosis patients. This is supported by the Cystic Fibrosis Peer review who visited the Trust and the proposed location for inpatients. 5.2. There have been several changes in Blue Outpatients that mean it would be possible to accommodate the Cystic Fibrosis and Bronchiectasis outpatient and day case services where there is a much higher chance that patients will need to be admitted to a bed from clinic. This would mean that Cystic Fibrosis services could be accommodated on one site and would also promote a stronger link with the Paediatric Cystic Fibrosis service to enable a more positive transition for patients and would particularly address the environmental disappointment that is currently experienced by patients moving from the new Children’s hospital to the dilapidated Churchill site. 5.3. The Diabetes and Endocrine patients who would remain on the Churchill site could be accommodated on John Warin ward on a cost-neutral basis within the existing nursing establishment and bed base. Although it would present some difficulties with regards the distance from OCDEM and the timing of some endocrine diagnostic tests, these issues should be able to be resolved with clear guidelines and specific identification of staff to take responsibility for those patients when they are on the ward. 5.4. The vacation of Geoffrey Harris ward at the Churchill presents other opportunities to facilitate the relocation of other services that need to remain on the Churchill site. This could include Respiratory outpatients and sleep and ventilation services as detailed above. 6. Objectives and Benefit Criteria 6.1. The objectives for a relocation of Respiratory services are set out below: To relocate Respiratory inpatient services to the John Radcliffe Hospital site to facilitate a more timely intervention of respiratory specialist expertise in the TB2015.56 Proposal for Respiratory Relocation Page 10 of 18 Oxford University Hospitals TB2015.56 management of acute respiratory referrals to ED and EAU and to meet national quality standards e.g. NICE COPD standards. To support the Acute General Medicine review from 2012 and the model for specialist input at an early stage. To support patients who need a higher level of respiratory intervention such as Non-invasive Ventilation. To move clinical services to better accommodation and vacate poor estate which has a high risk of power failure and does not meet current standards for an appropriate clinical environment. To ensure that Cystic Fibrosis patients, who have a high risk of being admitted, are co-located with inpatient services to reduce the on-going risk of patients needing to travel between sites. 6.2. The benefit criteria for a move of respiratory services are as follows: The opportunity for a more timely intervention from a respiratory specialist in the acute general medicine pathway. A reduced length of stay for patients with respiratory conditions being looked after by Respiratory medicine. Increased ability to move the most acute respiratory patients to the respiratory ward to maximise the expertise available. A reduction in delays to the pathway of care for complex patients who require multiple specialist opinions including respiratory. Delivery of the service specification for Cystic Fibrosis services as determined by patients and commissioners and monitored by the Cystic Fibrosis Trust through peer review. An increase in teaching and education for nurses and doctors in the management of respiratory conditions on other wards. 7. Options 7.1. Do Nothing 7.1.1. The option to do nothing has been discounted as doing nothing will deliver none of the objectives listed above and the option to remain in the existing configuration is not going to be possible in the long term due to problems with the estate and infrastructure on the Churchill site and the continued split between respiratory and acute general medicine which does not facilitate an effective pathway for patients admitted with an acute respiratory condition. 7.2. Relocation of All Respiratory Services 7.2.1. The option to put all Respiratory services on the John Radcliffe site has been discounted as there is insufficient space for the volume of ambulatory respiratory patients both within the hospital premises itself and also within the parking facilities for patients. This will mean that some services have to remain in sub-standard accommodation at the Churchill for the time being but it is important not to lose the opportunity to move some services and further the links and integration with Acute General Medicine. 7.3. Recommended Option: Move Respiratory Inpatients and Cystic Fibrosis Services TB2015.56 Proposal for Respiratory Relocation Page 11 of 18 Oxford University Hospitals 8. TB2015.56 7.3.1. The opportunity to move the Respiratory Ward and the Cystic Fibrosis services to vacated ward space on Level 7 and Level 5 and to Blue Outpatients on Level 2 will meet all the objectives and benefit criteria set out in sections 9 and 10 above and fits with the Trust strategy for the relocation of Respiratory services to facilitate the Acute Medical pathway. 7.3.2. In addition to the relocation of the Cystic Fibrosis and Bronchiectasis service to Blue Outpatients, it is recommended that a Lung Function testing room is also established alongside that facility. This will not only support Cystic Fibrosis patients but will also facilitate Cardiothoracic patients being tested without the need to be transferred to the Churchill site. It will also facilitate advanced diagnostic tests on acute respiratory patients that might help to avert an admission to hospital as part of the enhanced input of respiratory medicine to the acute medical flow. 7.3.3. Although this option does not address all of the accommodation problems for Respiratory services at the Churchill site, it does allow the service to move a further step forward in accommodating its services in a facility that meets the standard of twenty first century healthcare in a world class University Hospital. Financial Analysis of Preferred Option 8.1. Capital Costs 8.1.1. The cost of reconfiguring Level 7 is £1.774 million and the detailed costing is attached as Appendix B. The costs are high as they include some extensive works to install medical gases to all the bed-heads, removal of asbestos, a number of configuration changes on the ward to open the space out from its current configuration to enable improved observation of patients, and installation of ducting to allow future installation of mechanical ventilation. Derogation in place for a period of 2 years following which a further assessment will need to be made re the installation of the mechanical ventilation. 8.1.2. As the works are largely the reconfiguration of space within the existing footprint, the capital cost will not be added at 100% to the Depreciated Replacement Cost. The exception will be the Mechanical and Engineering (M&E) costs, where real value is added to the asset, in particular through the installation of medical gases to all bed-heads and installation of ducting to allow future installation of mechanical ventilation. M&E costs are estimated at £665k (including ducting). Assuming a 30 year life this gives depreciation of £22k/per annum and cost of capital of a further £19k/per annum. 8.1.3. There are some equipment costs as follows: Replacement monitoring for High care / HDU patients which will include a centralised monitoring station at the nurses base for maximum patient support: £90,000. The present monitoring equipment is old and it has been recommended that it should be replaced due to the likelihood of failure if it is transferred to the new facility. TB2015.56 Proposal for Respiratory Relocation Page 12 of 18 Oxford University Hospitals TB2015.56 14 EPR computers and wall-mounted arms for bed spaces on the main respiratory ward on Level 7. The costs for this have not been confirmed at the time of writing this case and are estimated at £20,000. Additional Lung Function testing facility within Blue Outpatients to support Cystic Fibrosis patients, admission avoidance for acute admissions and diagnostic tests for Cardiothoracic patients: £34,000. Some minor equipment requirements for the relocation of services and duplication of equipment that will be needed on the two sites. This is estimated as £10,000 for the purposes of the business case. 8.1.4. The estimated total for equipment is £154k. At an economic life of 5 years, this gives depreciation of £31k p.a. and cost of capital of £5k. 8.1.5. In addition to the above capital costs there will be some set-up costs that will be required to support the relocation – in particular the physical move of the ward and additional staff time to support packing and transfer of patients during the move itself. This is estimated at £30k. These costs will be treated as enabling costs for the capital works and therefore as capital in nature. They will not add to the Depreciated Replacement Cost so there are no capital charge implications. 8.1.6. Provision has been made in the Capital Programme to support the capital costs of this proposal. 8.1.7. Procurement will be via the Managed Term Contract (MTC). 8.2. Revenue Costs 8.2.1. Staffing a split site clinical unit introduces unavoidable inefficiencies which have been minimised as far as possible and are detailed below: Service Area Reason Resource Required Cost Occupational and Physiotherapy Currently the teams are configured to work flexibly according to patient need between the medical wards at the Churchill. The split site configuration will require additional staff to support timely intervention for the respiratory ward in its new location without loss of service to Renal and Infectious Diseases 1WTE across the services £33,800 Pharmacy Pharmacy input is already under pressure due to the split support required in Cystic fibrosis, outpatients and the ward and also the growth in homecare prescriptions to be dispensed in respiratory services. Pharmacy have found funding for half a post for the antimicrobial service and would put this with funding to make a full-time post which, together with the existing post would provide full cover for the ward and the outpatient services within the Churchill team across the two sites. 0.5 Band 7 £24,400 TB2015.56 Proposal for Respiratory Relocation Page 13 of 18 Oxford University Hospitals TB2015.56 Service Area Reason Resource Required Cost Respiratory SHOs This post will be required to support the increase in respiratory beds and split configuration for the Cystic Fibrosis patients who will be based on level 5. This post will also improve the workload within the existing team and protect the compliance of the rota 1 WTE CMT Post with 1A banding £58,500 Respiratory Middle Grades This post will enable the creation of a single Respiratory middle grade rota which will support Respiratory at the JR and remove the current shared requirement between ID and Respiratory which will not work across the split sites. The rota will also include some contribution to Acute General Medicine 1WTE clinical fellow with 1A banding £87,000 Respiratory Consultants To reinstate specialty outpatient activity that will be lost. Currently consultants are able to maintain their 2 clinics per week whilst also providing ward cover. This will not be possible due to split-site working. 3PAs £39,000 Total Staffing £242,700 Capital charges - building £41,000 Capital charges - equipment £36,000 Estates operational costs £10,000 Total 8.2.2. £329,700 Radiology and Pathology have been consulted during the development of the relocation proposal and have not identified any resource issues. There will be some operational matters that will need to be addressed including the switch in scanning requirements from the Churchill to the JR and reporting of these but the assessment of the workload has indicated that the total number of CT scans requested by the Respiratory ward is relatively minimal and the greatest pressure on radiology comes from Respiratory outpatients which will be remaining at the Churchill site. 8.3. Income 8.3.1. There may be a change in income as a result of moving more respiratory work to be managed on an ambulatory basis but there are opportunities for best practice tariff in some of these cases and the continued, anticipated increase in acute admissions is likely to offset the gains in ambulatory management. There is a potential risk to tertiary income for non-invasive ventilation referrals from other hospitals and cystic fibrosis patients within the local catchment area if those patients cannot be admitted. The proposed scheme mitigates this risk with the establishment of separate dedicated beds for Cystic Fibrosis patients. TB2015.56 Proposal for Respiratory Relocation Page 14 of 18 Oxford University Hospitals 9. TB2015.56 Contribution 9.1. Chest Medicine made a contribution of £2,626k to end of Q3 of 2014/15. Grossing up to full year effect gives £3,502k. The revenue costs noted above would reduce this to £3,172k. The contribution margin reduces from 26.2% to 23.7%. 10. Impact on Profitability 10.1. Chest Medicine makes a profit of £1,113k to end of Q3 of 2014/15. Grossing up to full year effect gives £1,484k The revenue costs noted above would reduce this to £1,155k. The profit margin reduces from 11.1% to 8.6%. 11. Market Assessment (including commissioner discussions) 11.1. Commissioners are very keen to have more specialist respiratory expertise available to support medical admissions and in the past have identified socalled “frequent fliers” and also drawn attention to the length of stay for some patients, particularly when they are admitted over the weekend. 12. Benefits Realisation 12.1. The table below shows the quantifiable benefits of the proposal and the plan for achieving them. Benefit Performance Measure Current Value Target Value Reduced length of stay for patients admitted with Respiratory Conditions Length of stay Reduction in readmissions for patients with COPD Readmissions within Assessment of baseline will be 28 days for COPD undertaken to inform a Divisionally agreed target Earlier intervention of a Respiratory specialist opinion in acute medical admissions Number of patients referred to and seen by the Respiratory team Delivery of BTS and NICE guidelines for Respiratory conditions eg Asthma, Bronchiectasis, COPD, NIV, Compliance with guidelines and improvement in current gap analysis Avoidance of admission of patients with Respiratory conditions Number of patients discharged from EAU with Respiratory condition on same day of admission. TB2015.56 Proposal for Respiratory Relocation Target Date Assessment of baseline will be undertaken to inform a Divisionally agreed target Assessment of baseline will be undertaken to inform a Divisionally agreed target Assessment of baseline will be undertaken to inform a Divisionally agreed target Page 15 of 18 Oxford University Hospitals TB2015.56 13. Management of Risks of Implementation of Proposal 13.1. An extensive Risk and Action Log has been produced as part of the project management arrangements for the relocation of service and this is attached as Appendix C. Many of the risks will be resolved by agreement for funding and recruitment to the additional posts identified. 13.2. There will be some risks associated with the management of respiratory patients as inpatients on the Churchill site – particularly patients who are post a radiology procedure such as a lung ablation or guided biopsy. These patients will be accommodated on John Warin ward and will need to be subject to clear protocols for management and agreed medical staffing responsibility. 13.3. The Respiratory service remains extremely concerned that there is no agreed solution for the remaining services on the Churchill site which continue to operate from sub-standard facilities. 14. Implementation Plan 14.1. If approval is given for this scheme to proceed, it is anticipated that the building refurbishment of Level 7 will take approximately 20 weeks. Enabling works have already begun which has reduced the risk of the programme being even longer. Detailed discussion on room requirements have already taken place which has also helped with reducing the length of the build programme. 14.2. A project team has been set up with a detailed action plan for all the work that will need to take place prior to the relocation. This group is chaired by the Clinical Director for Ambulatory Medicine and the Project is being managed by the Operational Service Manager for Ambulatory. This group had been meeting weekly during the development of this proposal and some of the initial work to discuss the operational arrangements for the future configuration and to mitigate against the risks associated with the planned move. This group is currently meeting monthly but will increase the frequency of the meetings pending approval of the business case to ensure that all actions to support the move are completed. The group has accountability to the MRC division for delivery of this project. Staff have been kept fully informed of the relocation plans for the service but a formal consultation for staff would be issued in June for to ensure that all issues are considered and staff are supported with plans for relocation. 14.3. Recruitment for additional staff would commence pending approval of this case to proceed. A meeting has been arranged between Respiratory, JR and Horton Acute General Medicine to look at the best configuration of consultant job plans that will work between Oxford and Banbury and across Respiratory and Medicine. Locum posts will be advertised alongside substantive posts to support maintaining service cover on an interim basis. This is a particularly acute issue due to the resignation of both the substantive and locum consultants for Respiratory at the Horton. 14.4. There will need to be some more detailed pathway work between Respiratory and Acute General Medicine to consider the model of care and to agree how patients will be managed that are across the specialties given that the total number of respiratory patients will regularly exceed the number of respiratory beds available. This work will be led by Dr Maxine Hardinge as the Clinical Lead for Respiratory and Dr Sudhir Singh as the Clinical Lead for Medicine. TB2015.56 Proposal for Respiratory Relocation Page 16 of 18 Oxford University Hospitals TB2015.56 14.5. The options for out-of-hours rotas will be finalised and an implementation date agreed in order to communicate with the junior staff who will be affected and to allow time for services to consider the impact on day time capacity. Contingency plans for delays and/or overlap of the rotas and project will be drawn up to ensure that there are no gaps in cover. The work on doctors’ rotas is being led by Professor Tim Peto who led the work to establish the out-ofhours rotas for the Churchill site when the Cancer Centre opened in 2008. 14.6. A detailed operational policy will be written to fully document which services are working in which location and what contingency arrangements are in place if patients need to transfer. 15. When and how will the impact and intended effect be reviewed and reported on? 15.1. The relocation will be reported on in December 2015 through the MRC Division following the initial move. A formal review of the move and the impact will be provided in a report to TME in April 2016 once the service has settled and it is easier to assess how the service is working and what the impact has been. 16. Conclusion 16.1. The decision to relocate respiratory inpatient services to the John Radcliffe site has already been made as part of the Trust’s strategy for configuration of services. There are a number of quality benefits associated with this reconfiguration, with increased efficiency in the support of the patient pathway for patients admitted with acute respiratory conditions. There are also other opportunities such as the closer liaison and development of thoracic services in partnership with the Thoracic surgeons which will also support and strengthen the cancer pathway as there are increasing efforts to encourage more patients to have a surgical intervention for their cancer. 16.2. There are a number of difficult implications for the move which include the lack of resolution for remaining services in the old accommodation on the Churchill site. The move of inpatient services will result in a different split in services that will have risks associated with it such as the reduction in support for patients on the Churchill site in terms of both medical input for cancer, surgical and diagnostic patients, and potentially a different break in the patient pathway for respiratory diagnostic and outpatients who may require acute admission and may need to transfer to the John Radcliffe site. These risks will continue to be considered and actively addressed through the work of the project team that has been established to support the move. 16.3. Delivery of this business case will result in the following configuration of services in Respiratory Medicine within the Trust: Respiratory Service Location Inpatient Ward John Radcliffe Hospital Cystic Fibrosis Inpatients John Radcliffe Hospital Cystic Fibrosis Day Case and Outpatients John Radcliffe Hospital Interventional work – Bronchoscopy and Pleural John Radcliffe Hospital TB2015.56 Proposal for Respiratory Relocation Page 17 of 18 Oxford University Hospitals TB2015.56 Respiratory Service Location Inpatient Sleep Studies John Radcliffe Hospital Respiratory Day Treatments John Radcliffe Hospital Respiratory Outpatients including remaining sub-specialties and lung cancer Churchill Hospital Respiratory Outpatient Radiology Investigations – CT and Plain Film X-ray Churchill Hospital Sleep and Ventilation Outpatients and Sleep Apnoea and Ventilator set-ups Churchill Hospital Lung Function Testing Churchill Hospital Interventional Radiology procedures for Lung Cancer patients Churchill Hospital Radiology admissions Churchill Hospital (John Warin Ward) 17. Recommendations 17.1. The Trust Board is asked to: Approve the proposed reconfiguration of Respiratory services and to note the associated risks and to support the services to minimise the risks as a result of the move. The Trust is asked to support either a reconfiguration or some investment in infrastructure to improve the environment for services remaining on the Churchill site whilst a final Churchill site strategy is developed. The Trust is asked to approve the additional revenue and capital resources required to facilitate the reconfiguration of services. Paul Brennan, Director of Clinical Services Authors: Dr Hywel Jones, Divisional Director, Emergency, Medicine, Therapies and Ambulatory Dr Maxine Hardinge, Clinical Lead for Respiratory Services Mrs Kathryn Hall, Operational Services Manager Mr Andrew Hall, Interim Senior Business Partner May 2015 TB2015.56 Proposal for Respiratory Relocation Page 18 of 18 Business Case: EXPENDITURE Relocation of Respiratory Services Baseline/ budget Proposal 2014/15 WTE 2014/15 WTE 2015/16 WTE 2016/17 WTE 2017/18 WTE 2018/19 WTE 2019/20 WTE Baseline/bud get Proposal 2014/15 2015/16 £000s 2014/15 £000s £000s 2016/17 £000s 2017/18 £000s 2018/19 £000s 2019/20 £000s A. Direct revenue costs Staff (specify grade & wte) Consultants 0.30 0.30 0.30 0.30 0.30 19 39 39 39 39 Sub total 0.00 0.00 0.30 2.00 0.30 2.00 0.30 2.00 0.30 2.00 0.30 2.00 0 0 19 73 39 146 39 146 39 146 39 146 Sub total 0.00 0.00 2.00 2.00 2.00 2.00 2.00 0 0 73 146 146 146 146 Sub total 0.00 0.00 0.00 1.50 0.00 1.50 0.00 1.50 0.00 1.50 0.00 1.50 0 0 0 29 0 58 0 58 0 58 0 58 Sub total 0.00 0.00 1.50 1.50 1.50 1.50 1.50 0 0 29 58 58 58 58 Sub total 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 0 0 0 0 0 0 Sub total 0.00 0.00 0.00 0.00 0.00 3.80 0.00 3.80 0.00 3.80 0.00 3.80 0.00 3.80 0 0 0 0 0 121 0 243 0 243 0 243 0 243 10 10 10 10 Junior Medical Nursing Scientific & Therapeutic Other Clinical Non Clinical Total Staff Non-Staff (inc VAT) Estates operatinal costs Total non staff Total Direct Revenue costs A 0 0 0 10 10 10 10 0 0 121 253 253 253 253 B. Indirect revenue costs Staff (specify grade & wte) Radiological Sciences Sub total Pharmacy 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 Sub total Therapies 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 Sub total Laboratory Medicine 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 Sub total Theatres/Anaesthetics 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 Sub total Critical Care 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 Sub total Others 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 Sub total Total Staff 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Non Staff (please insert lines and descriptions) Radiological Sciences Pharmacy Laboratory Medicine Theatres/Anaesthetics Critical Care Equipment servicing Revenue set up costs (e.g. IT, Furniture, fittings etc) Outpatient costs Facillities Costs (e.g. catering, linen) Others Total non staff Total Indirect Revenue costs B C. Capital Expenditure Building Equipment Relocation 1,774 154 30 C. Capital Expenditure D. Capital Charge & Depreciation C D 0 0 1,958 38 0 77 0 77 0 77 0 77 E. Contribution to Corporate Overheads @ 15% E 0 0 0 0 0 0 0 F. TOTAL REVENUE COST F 0 0 159 330 330 330 330 Appendix A - Financial Pro forma Respiratory Relocation Business Case re... 05/05/2015 Business Case: Activity & Income G. Activity (specify HRGs) A & E attendances Emergency HRGs Relocation of Respiratory Services Baseline/ budget Proposal 2014/15 2015/16 2014/15 2016/17 2017/18 2018/19 2019/20 Subtotal emergency Elective HRGs 0 0 0 0 0 0 0 Subtotal elective Day Case HRGs 0 0 0 0 0 0 0 Subtotal daycase Outpatient new Outpatient follow-up Subtotal outpatient Other Other 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H. Income A & E attendances Emergency HRGs Elective HRGs Day Case HRGs Outpatient new Outpatient follow-up Other Other £000s £000s £000s £000s £000s £000s £000s Subtotal NHS/PCT 0 0 0 0 0 0 0 Total Income 0 0 0 0 0 0 0 Private Patient R&D Other non NHS clinical Charitable Funds Other Analysis of income by Specialised/Non-Specialised Commissioner The following table is to indicate changes to current Commissioner income flows. If future years will alter significantly from this please make clear reference in your business case narrative. For non-specialised services, please analyse by CCG. 2015/16 Activity Spells Source of Income A&E Emergency Other OP- New/Fup Day case Elective Commissioner Sub total NHS/PCT 0 0 0 0 0 0 Total 0 0 0 0 0 0 Private Patient R&D Other non NHS clinical Charitable Funds Other 2015/16 Income Source of Income Commissioner Spells A&E Emergency Elective Day case OP- New/Fup £000s £000s £000s £000s £000s Other £000s Sub total NHS/PCT 0 0 0 0 0 0 Total 0 0 0 0 0 0 Private Patient R&D Other non NHS clinical Charitable Funds Other Appendix A - Financial Pro forma Respiratory Relocation Business Case re... 05/05/2015 Business Case: Relocation of Respiratory Services Baseline/ budget SUMMARY 2014/15 WTE Baseline/ budget Proposal 2014/15 WTE 2015/16 WTE 2016/17 WTE 2017/18 WTE 2018/19 WTE 2019/20 WTE Proposal 2014/15 2015/16 £000s 2014/15 £000s £000s 2016/17 £000s 2017/18 £000s 2018/19 £000s 2019/20 £000s A. Direct revenue costs Staff Consultants Junior Medical Nursing Scientific & Therapeutic Other Clinical Non Clinical 0.00 0.00 0.00 0.00 0.00 0.00 Total Staff 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.30 2.00 0.00 1.50 0.00 0.00 3.80 0.30 2.00 0.00 1.50 0.00 0.00 3.80 0.30 2.00 0.00 1.50 0.00 0.00 3.80 0.30 2.00 0.00 1.50 0.00 0.00 3.80 0.30 2.00 0.00 1.50 0.00 0.00 3.80 Non-Staff Subtotal Direct costs A 0 0 0 0 0 0 0 0 0 0 0 0 19 73 0 29 0 0 39 146 0 58 0 0 39 146 0 58 0 0 39 146 0 58 0 0 39 146 0 58 0 0 0 0 121 243 243 243 243 0 0 0 10 10 10 10 0.00 0.00 3.80 3.80 3.80 3.80 3.80 0 0 121 253 253 253 253 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B. Indirect revenue costs Staff Radiological Sciences Pharmacy Therapies Laboratory Medicine Theatres/Anaesthetics Critical Care Others Total Staff Non Staff Subtotal Indirect costs B 0.00 0.00 0.00 0.00 0.00 0.00 0.00 C. Capital Expenditure D. Capital Charge & Depreciation C D 0 0 0 0 1,958 38 0 77 0 77 0 77 0 77 E. Contribution to Corporate Overheads @ 15% E 0 0 0 0 0 0 0 F. TOTAL REVENUE COST F 0 0 159 330 330 330 330 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H. Income Total PCT Private Patient R&D Other non NHS clinical Charitable Funds Other Total Income H SURPLUS (DEFICIT) Appendix A - Financial Pro forma Respiratory Relocation Business Case re... 05/05/2015 0 0 0 0 0 0 0 0 0 -159 -330 -330 -330 -330 Business Case: Relocation of Respiratory Services Baseline/ budget INCREMENTAL SUMMARY 2014/15 WTE Baseline/ budget Proposal 2014/15 WTE 2015/16 WTE 2016/17 WTE 2017/18 WTE 2018/19 WTE 2019/20 WTE 2014/15 £000s Proposal 2015/16 £000s 2014/15 £000s 2016/17 £000s 2017/18 £000s 2018/19 £000s 2019/20 £000s A. Direct revenue costs Staff Consultants Junior Medical Nursing Scientific & Therapeutic Other Clinical Non Clinical 0.00 0.00 0.00 0.00 0.00 0.00 Total Staff 0.00 0.30 2.00 0.00 1.50 0.00 0.00 3.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non-Staff Subtotal Direct costs A 0 0 0 0 0 0 19 73 0 29 0 0 20 73 0 29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 121 122 0 0 0 0 0 10 0 0 0 0.00 3.80 0.00 0.00 0.00 0.00 0 121 132 0 0 0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B. Indirect revenue costs Staff Radiological Sciences Pharmacy Therapies Laboratory Medicine Theatres/Anaesthetics Critical Care Others Total Staff Non Staff Subtotal Indirect costs B 0.00 0.00 0.00 0.00 0.00 0.00 C. Capital Expenditure D. Capital Charge & Depreciation C D 0 0 1,958 38 -1,958 39 0 0 0 0 0 0 E. Contribution to Corporate Overheads @ 15% E 0 0 0 0 0 0 F. TOTAL REVENUE COST F 0 159 171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H. Income Total PCT Private Patient R&D Other non NHS clinical Charitable Funds Other Total Income SURPLUS (DEFICIT) H 0 0 0 0 0 0 0 -159 -171 0 0 0 BUDGET ESTIMATE Detailed Design Project Number 2014.203 Capital Programme Capital Code: 7189 Project Name Project Option Ward 7E Respiratory Refurbishment With ducting only for mech vent Outturn 13/14 Allocation 14/15 £0 £400,000 Project Manager DATE: Mark Bristow 6th March 2015 Total Charitable Fund £400,000 £0 Work Stage Completion of det design Overall Capital Programme Allocation £400,000 Procurement Strategy MTC therefore no allowance for prelims Initial Estimate base docs~ GBS drawings 6514.200-701, Method drawings Medical gases & M&E services. Please note that this Estimate is a preliminary cost based upon outline sketch proposals and is subject to change during the detailed design stages. Cost per m2 (£/m2) Construction Notes/ Qualification % Construction costs -Building Costs -M&E Costs Ducting only for future vent -Phasing Cost Sub- Total Construction contingencies Total Construction m2 cost based on HPCG's plus allowances for abnormals 10.00% £ breakdown below £251,022 £465,174 £200,000 £0 £916,196 Excludes: Construction Contingency £91,620 £1,007,816 Includes: Construction Contingency Professional Fees (VAT 100% recoverable) Assumed 15% of Construction Costs 15.00% £151,172 Includes: Design, Professional, Building Contol, Planning and Survey Fees 5% £50,391 Includes: Trust Signage, Cleaning, Trust Project Team and Decant Costs. Non Works 5% of Total Construction Costs Group 2 & 3 Equipment £0 none allowed for included separately in business case none Sub Total £1,209,379 Includes: Total Construction, Professional Fees, Non-Works and Group 2&3 Equipment Costs Planning Contingencies Assumed 10% of Total Construction Cost 10.00% Total Cost Applied to Sub-Total. Includes: Cost Overruns not contained within building contract contingencies, claims for £120,938 disruption and loss and expense, cost overruns on equipment budget, claims for additional professional fees £1,330,317 Optimism Bias Estimated 17.01% of Overall Construction and Contingencies Cost 14.03% Applied to Total Cost. Includes: changes to scope of project incl. for example developments in national policy, changes in local priorities and strategies, changes in medical technology, changes in how services are £186,643 delivered. Inflation to 2Q2015 2.20% £33,373 Cost at date of issue VAT % (Excluding Fees) 20.00% Applied to Total Construction, Non-works, Group 2 & 3 Equipment, Planning Contingency, Optimisim Bias and £279,832 Inflation Costs Recoverable VAT 20,40 or 75%. 20.00% Total Scheme Cost £55,966 No independent objective assessment of VAT abatement has been undertaken £1,774,199 \\OXNETORHESTFS01\Estates&Facilities\Estates Planning & Development\Development\Jr Projects\2014.203 Ward 7E Geoffrey Harris Ward\1.Costs\InEsts\2014.203 ward 7E detailed design estimate mech vent ducting only 11/03/2015 1 Other ward equipment required to be confirmed. Current options: Small room utilised by Estates services as a kitchen / staff room. Sharing the relative’s area on the Post-Acute Unit (PAU), however this is not ideal. Current options: Office in Blue Outpatients. Divisional Nurses office on Level 7, C/D corridor. To obtain update on room options. Resource requirements: Centralised monitoring system for high-care patients: four monitors plus a central console costing £90,000 is included in the business case Risk Rating (Feb-15) L C 1 5 5 20 5 1 ↔ 5 2 10 5 Risk Rating (Apr-15) L C 5 2 10 4 5 20 Trend Updated 24/02/2015 5 Immediate Principal Risk 1: Ward Accommodation Lack of relative’s room: 1.1 L’OC Cause: Insufficient space within the current ward plans to incorporate a relative’s room. Effect: Lack of dedicated space for visitors to the ward, and to have private conversations with relatives and carers about patient care. Impact: Poor experience for patient relatives and carers. Lack of Consultant’s office: 1.2 L’OC Cause: Insufficient space within the current ward plans to incorporate a Consultant’s office. Effect: Lack of dedicated space for Consultants who do not have an office on the JR site. Impact: Consultants not set up to facilitate cross-site working. Consultant proximity to the ward important for patient safety / junior staff supervision. Provision of monitoring equipment: 1.3 Cause: Lack of monitoring equipment for high-care patients. Effect: Ward environment not currently suitable for high-care patients. Impact: Compromising patient safety for high-care patients. Immediate RISK DESCRIPTION KEY CONTROLS & CONTINGENCY PLANS Proximity Respiratory Relocation – Risk & Action Log Immediate Source Risk Owner RISK ID Oxford University Hospitals 4 Last Review Target L C 3.2 Senior House Officers: Provisional plan for inpatients to be located on ward 5C / 5D. This needs to be confirmed including identified area for these patients Training and Development plans need to be agreed and delivered for staff on 5C/5D The use of the pre-assessment space and five rooms in Blue Outpatients has been requested. Office space to support the Cystic Fibrosis team has also been requested. A room for lung function has been requested Provision of the post has been agreed with MRC Division Education Lead Doctors have been interviewed for the posts although no doctor has been specifically allocated to the post The additional CMT post will help Risk Rating (Feb-15) L C 3 Risk Rating (Apr-15) L C 4 3 ↔ 12 12 4x3= 12 4x3= 12 4 4 16 3 2 4 8 4 3 Trend Updated 24/02/2015 4 Immediate Principal Risk 2: Cystic Fibrosis Patients Plan for Cystic Fibrosis inpatients: 2.1 L’OC Cause: No confirmed plan for accommodation of Cystic Fibrosis inpatients. Effect: The provision of inpatient beds for Cystic Fibrosis patients is unknown. The skill mix and training for relevant nursing staff needs to be discussed. Impact: Cystic Fibrosis service cannot function without an agreement for the management of inpatients. Cystic Fibrosis in Blue Outpatients: 2.2 L’OC Cause: No confirmed plan for provision KH of accommodation for the Cystic Fibrosis Service. Effect: The provision of Cystic Fibrosis outpatients is unknown. Impact: Cystic Fibrosis service cannot function without an agreement for the management of outpatients. Principal Risk 3: Staffing Junior medical staff: 3.1 Cause: An additional CMT post is required to support the increase in Respiratory beds and also the separate ward support that will be required for the Cystic Fibrosis patients. Effect: Lack of agreed funding and time taken to recruit. Impact: Gaps in service provision with impact on daytime workload and outof-hours on-call Immediate RISK DESCRIPTION KEY CONTROLS & CONTINGENCY PLANS Proximity Respiratory Relocation – Risk & Action Log Immediate Source Risk Owner RISK ID Oxford University Hospitals 4 Last Review Target L C Cause: There is no agreed plan to cover the SHO night rota. Effect: Lack of agreed funding and time taken to recruit. Impact: Gaps in service provision. 3.3 Middle grade medical staff: Cause: Three additional Clinical Fellows are required to cover a separate Respiratory Medicine middle grade rota. There is a lack of funding for one of these posts. Effect: Lack of agreed funding and time taken to recruit. Impact: Gaps in service provision. 3.4 Consultants: Cause: There is no agreed plan for Churchill ward cover. Effect: Gap in Service Provision address rota issues and workload within the existing team and protect compliance of the rota. There are ongoing discussions with Geratology and Gastro about reconfiguring their SHO rotas to fit with the contribution of respiratory medicine These posts will be added to the current Specialist Registrar rota to create a single Respiratory middle grade rota to support Respiratory at the JR. It will also remove the current shared requirement between Infectious Diseases and Respiratory which will not work across the split sites. The remaining post that is required to support the rota is also required to deliver activity within the ILD service due to loss of research fellow contribution. The post is currently being advertised at risk to avoid other financial consequences and impact on income and contract performance The removal of Respiratory Registrars from the Churchill site is not expected to have a detrimental impact on the Churchill Hospital at Night rota due to additional contributions from doctors at the Churchill This is to facilitate the maintenance of Respiratory outpatient capacity to meet the 18 week target. Currently Risk Rating (Feb-15) L C 3 12 4 12 2 4 Risk Rating (Apr-15) L C 3 4 12 2 2 4 2 Trend Updated 24/02/2015 12 Immediate RISK DESCRIPTION KEY CONTROLS & CONTINGENCY PLANS Proximity Respiratory Relocation – Risk & Action Log Immedi ate Source Risk Owner RISK ID Oxford University Hospitals Last Review Target L C 3.7 3.8 Nursing: Cause: The ward establishment in line with the number of beds and acuity of patients has not yet been agreed. The ward also currently has vacancies for Consultants maintain outpatient clinics whilst on-call for the ward. This will not be possible when split across 2 sites. This usually amounts to 2 clinics in the week which is a total of 3 PAs per week including clinical admin time. The provision of a daily referrals service at the JR on the medical wards and EAU will require 4 hours per day therefore 5PAs. In addition it has been requested that a daily urgent clinic is provided which will require further resource The service requirement has been identified as 10 hours of Band 6 nurse time. The Sleep & Ventilation Nurses currently provide a predominantly outpatient based service but also need to visit the ward daily to support inpatients on NIV treatment and help with discharge home for those patients. The Directorate will review the establishment across all nursing budgets and consider options for how to address the acuity and dependency of the patients in the Risk Rating (Feb-15) L C 4 20 5 3 20 4 5 3 15 3 15 5 5 20 15 5 Risk Rating (Apr-15) L C 5 3 15 4 5 20 4 Trend Proximity Updated 24/02/2015 5 Immediate Impact: Delay to receiving timely advice for ongoing patient management. Consultants: Cause: There is no agreed plan for split site working and the cover of Outpatients clinics. Effect: Gap in service provision Impact: Increase in waiting time which may impact on delivery of the 18 week target as well as the management of more urgent patients Consultants: Cause: There is no agreed plan or agreed funding for the JR referrals service. Effect: Gap in service provision Impact: Delay to delivery of advice and care plan for patients which may also impact on length of stay Sleep & Ventilation Service: Cause: Additional hours are required for Sleep & Ventilation Nurses to attend cross-site ward visits. Effect: Gap in service provision Impact: Delay in patient care and increased length of stay Immediate Source RISK DESCRIPTION KEY CONTROLS & CONTINGENCY PLANS Immediate 3.6 Respiratory Relocation – Risk & Action Log Immediate 3.5 Risk Owner RISK ID Oxford University Hospitals Last Review Target L C 3.1 1 five Band 5 nurses and one Band 6 nurse. Effect: Gap in service provision Impact: Inability to maintain safe level of staffing for the acuity of the patient and delay to treatment and increased length of stay Physiotherapy: Cause: Additional Physiotherapists are required for split site working and workload in respiratory outpatients Effect: Gap in service provision Impact: Delay to rehabilitation of patients and increased length of stay Occupational Therapy: Cause: Additional Occupational Therapists are required for split site working. Effect: Gap in service provision Impact: Delay to rehabilitation and increased length of stay Pharmacy: Cause: Additional Pharmacists are required for split site working. Effect: Gap in service provision Impact: Failure to meet Trust quality standards – Medicines reconciliation completed within 24 hours of admission Failure to meet Trust TTO turnaround target Significant increase in risk related to medicine errors, omissions and drug related readmissions Resource requirements: 0.8 WTE Band 6 to provide supervision and support for complex Respiratory patients at the JR site and to protect Respiratory Physiotherapy outpatient capacity. Resource requirements: Minimum staffing required will be 0.5WTE Band 6. 0.5 Band 3 to support both Occupational Therapy and Physiotherapy. Resource requirements: Additional 0.5 Band 7 Pharmacist and 1.0 WTE Pharmacy Technician. Pharmacy have found funding for half a post for antimicrobial service and would put this with funding to make a full-time post which would provide full cover for the ward and the outpatient services within the Churchill team. The Technician post will support rapid discharge and TTOs in line with the new electronic prescribing system. Updated 24/02/2015 Risk Rating (Feb-15) L C 5 3 15 5 15 5 3 15 3 15 5 Risk Rating (Apr-15) L C 5 3 15 3 5 15 3 Trend Proximity current and future bed configuration Immediate Source RISK DESCRIPTION KEY CONTROLS & CONTINGENCY PLANS Immediate 3.1 0 Respiratory Relocation – Risk & Action Log Immediate 3.9 Risk Owner RISK ID Oxford University Hospitals Last Review Target L C Significant cost pressures due to un-reviewed and nonformulary medications and medication waste No pharmacy support for nursing and medical training Ward stock management failures Gap in service provision Principal Risk 4: Critical Care Loss of Critical Care capacity at the 4.1 HB Churchill site: MH Cause: Withdrawal of Respiratory high-care beds. Effect: Reduced high-care capacity at the Churchill site, e.g. tracheostomy patients, weaning ventilator-dependent patients Impact: Reduced service access for critically unwell patients and potential delay to surgery or cancellation of transplant procedures Principal Risk 5: Radiology Procedures at Churchill Site Patients post-Radiology procedure: 5.1 Cause: Patients being admitted postRadiology procedure at the Churchill site will no longer be admitted to a Respiratory ward with the immediate availability of Respiratory trained staff. Effect: Patients to be managed on John Warin ward. Impact: Potential compromise to patient safety without support and expertise readily available. If ablations and biopsies remain on the Churchill site (John Warin ward) then there is a need to ensure support is provided by a Respiratory Consultant for advice. Patients should also be admitted under an Infectious Disease doctor to ensure timely medical management and responsibility. Draft protocol for the management of these patients. Risk Rating (Feb-15) L C 5 Critical Care Capacity is the subject of a separate business case Immediate Updated 24/02/2015 3 5 15 5 20 Risk Rating (Apr-15) L C 3 ↔ 15 4 5 15 Trend RISK DESCRIPTION KEY CONTROLS & CONTINGENCY PLANS Proximity Respiratory Relocation – Risk & Action Log Immediate Source Risk Owner RISK ID Oxford University Hospitals 3 Last Review Target L C Principal Risk 6: Pathways Daycase patients: 6.1 MH Cause: No agreed process for the admission and management of Daycase patients at the JR such as xolair treatment for chronic asthma and methalprenisalone . Effect: Delay to treatment of patients Impact: Reduction in ward capacity if patients need to be admitted to the Respiratory ward Principal Risk 7: Endocrine Bed Relocation Management of Endocrine pathway: 7.1 GT Cause: Endocrine inpatients will KH primarily be managed on John Warin ward rather than Geoffrey Harris ward. Effect: Additional training required for medical and nursing staff on John Warin ward to manage Endocrine patients. Impact: Care requirements of Endocrine inpatients not fulfilled. Principal Risk 8: Lung Function Lung function testing: 8.1 KH Cause: Lack of lung function testing L’OC equipment at the JR site. Effect: Patients will have to travel to the Churchill site in an ambulance for lung function tests. Impact: Logistical issues associated Nurse skills and competencies need to be considered and training provided. Some of these patients are already being accommodated on John Warin ward Plan is for patients to attend DDU on Level 4. Additional meeting required to start documenting pathways of care and back-up support for patients at the JR site. Training plan to be developed and delivered for nursing staff A plan is required for Infectious Diseases SHO allocation for Endocrine patients. A training plan is required for nursing staff Documented protocols for complex testing regimes to be drawn up Current options: Discussed requirement for lung function equipment based in outpatients to support rapid assessment of patients attending hospital through the Emergency Assessment Unit and other direct 3 Risk Rating (Apr-15) L C 4 15 Trend Risk Rating (Feb-15) L C 5 Immediate Updated 24/02/2015 3 12 5 Immediate RISK DESCRIPTION KEY CONTROLS & CONTINGENCY PLANS Proximity Respiratory Relocation – Risk & Action Log 3 5 15 5 Immediate Source Risk Owner RISK ID Oxford University Hospitals ↔ 15 3 15 3 5 3 15 ↔ Last Review Target L C KEY CONTROLS & CONTINGENCY PLANS with the above. pathways. This would positively impact upon patient diagnoses and reduce the number of Thoracic patients sent to the Churchill site for lung function tests. To obtain update on room availability in Blue Outpatients at the JR. Updated 24/02/2015 Risk Rating (Feb-15) L C Risk Rating (Apr-15) L C Trend RISK DESCRIPTION Respiratory Relocation – Risk & Action Log Proximity Source Risk Owner RISK ID Oxford University Hospitals Last Review Target L C Oxford University Hospitals Respiratory Relocation – Risk & Action Log Updated 24/02/2015 Key Risk Owners: MH HB GT KH SP RL Maxine Hardinge – Clinical Lead, Respiratory Medicine Henry Bettinson – Clinical Governance Lead, Respiratory Medicine Garry Tan – Clinical Lead, OCDEM Kathryn Hall – Operational Service Manager, Ambulatory Medicine Clinical Directorate Sarah Poole – Pharmacist, Respiratory Medicine Rachel Lardner – Physiotherapist, Respiratory Medicine Trend ↑ ↔ ↓ variable risk score increasing risk score remains static for rolling 12 months risk score reducing risk score changes up and down overtime L’OC IB LP PJ CJ WF Lily O’Connor – Divisional Nurse, Medicine, Rehabilitation & Cardiac Division Ivor Byren – Clinical Director, Ambulatory Medicine Clinical Directorate Lisa Priestley – Lead Nurse, Cystic Fibrosis Philippa Jeffcock – Clinical Unit Manager, Respiratory Medicine Cicy Jose – Ward Sister, Geoffrey Harris ward William Flight – Consultant, Cystic Fibrosis Oxford University Hospitals NHS Trust. Please include this in the preparation to write a policy and refer to the “Policy on Writing Policies.” Full guidance is available: http://ouh.oxnet.nhs.uk/Equality/Pages/EqualityImpactAssessment.aspx Equality Analysis Plan / proposal name: Relocation of Respiratory ward and Cystic Fibrosis day case and outpatient unit from Churchill to John Radcliffe site Date of Plan April 2015 Date due for review April 2018 Lead person for policy and equality analysis Kathryn Hall, Operational Service Manager, Ambulatory Directorate Does the policy /proposal relate to people? If yes please complete the whole form. YES The only policies and proposals not relevant to equality considerations are those not involving people at all. (E.g Equipment such as fridge temperature) 1. Identify the main aim and objectives and intended outcomes of the policy. Who will benefit from the policy? How is the policy likely to affect the promotion of equality and minimize discrimination considering: age, disability, sex/gender, gender re-assignment, race, religion or belief, sexual orientation, pregnancy and maternity, marriage or civil partnerships or human rights? Patients admitted to the John Radcliffe site with acute respiratory problems will benefit from the proposal through improved colocation and integration with AGM, supporting improved management of their pathway of care Patients treated within the Cystic Fibrosis service will benefit from improved accommodation and opportunities to enhance the transition from paediatric to adult services by being on the same site. 2. Involvement of stakeholders. List who has been involved in the policy/proposal development? The multi-disciplinary team within Respiratory Medicine including consultants, nurses, administrative staff, therapists, etc. The Cystic Fibrosis peer review team are also supportive of the proposal to relocate the service and there is also patient feedback to support the relocation. The Trust Equality Plans can be found on the website and on the Equality intranet site. Equality analysis version 8 February 2013. 1 Oxford University Hospitals NHS Trust. 3. Evidence. Population information on www.healthprofiles.info search for Oxfordshire. Disability Have you consulted with someone who has a physical or sensory impairment? How will this policy affect people who have a disability? There should be no impact on patients with a disability other than to reduce the requirement for these patients to move between sites as part of their inpatient pathway when admitted with an acute respiratory problem. Disability: learning disability There should be no impact Sex: How will this policy effect people of different gender? There should be no impact Age: How will this policy affect people of different ages? There should be no impact Race: How will this policy affect people of different race? There should be no impact Sexual orientations How will this policy effect people of different sexual orientation? There should be no impact Pregnancy and maternity There should be no impact Religion or belief. There should be no impact Gender re-assignment. There should be no impact Marriage or civil partnerships: There should be no impact Carers Remember to ensure carers are fully involved, informed, supported and they can express their concerns. Consider the need for flexible working. Carers for patients on the ward and the Cystic Fibrosis service should be supported through the reduction in requirement for patients to be transferred during their admission. Carers have also complained about the quality of the existing accommodation for Cystic Fibrosis patients and this move should address that. Safeguarding people who are vulnerable: How has this policy plan or proposal ensured that the organisation is safeguarding vulnerable people? (E.g. by providing communication aids or assistance in any other way.) The Trust Equality Plans can be found on the website and on the Equality intranet site. Equality analysis version 8 February 2013. 2 Oxford University Hospitals NHS Trust. Communication for patients and carers regarding the relocation will be undertaken in advance of the service move. Other potential impacts e.g. culture, human rights, socio economic e.g. homeless people There should be no impact Section 4 Summary of Analysis Does the evidence show any potential to discriminate? If your answer is no – you need to give the evidence for this decision. There is no evidence that this relocation shows any potential to discriminate. This should improve the pathway and the patient experience for patients who are admitted to the John Radcliffe with a respiratory condition. It should also improve the quality of the accommodation for Cystic Fibrosis outpatients and day cases as well as ensure they have access to fully-equipped side rooms when they are particularly unwell on the site of their admission. How does the policy advance equality of opportunity? This should improve access to a Respiratory Expert Opinion for Medical patients admitted to the John Radcliffe Hospital site and reduce delays in transferring acutely unwell patients to the respiratory ward. How does the policy promote good relations between groups? (Promoting understanding) The Trust Equality Plans can be found on the website and on the Equality intranet site. Equality analysis version 8 February 2013. 3